Default company panoramic image
184ce33a af3c 4013 b9e9 eebdd9b1355f

Chromatan Corporation

Column-Free, Single-Use purification for large scale manufacturing of life-saving biological products.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location State College, PA, USA
  • Currency USD
  • Founded January 2009
  • Employees 12
  • Incorporation Type C-corp
  • Website

Company Summary

Chromatan is commercializing a new purification platform to de-bottleneck large-scale manufacturing of life-saving biologics . We have shown up to 15-fold improvements and 65% cost reduction in multiple pilot studies with large biotechs like Merck and Regeneron.

In 2017 ChromaTan was awarded a $2.5 Million contract from the FDA. We are raising $2 Million to enable manufacturing, scale-up and sales of our process development system.


  • Default avatar
    Oleg Shinkazh

    Oleg Shinkazh, founder and CEO of Chromatan and the inventor of “Countercurrent Tangential Chromatography” is a chemical and biotechnology engineer with 11 years of experience in the biotechnology industry, specializing in downstream processing and purification of biologics. Oleg has been with Chromatan since October 2009, leading technical and business development of the company.

  • Default avatar
    Dr. Andrew Zydney
    Board member

    Dr. Andrew Zydney is the Chemical Engineering Department Head at Penn State University. He is one of the leading researchers in the bioseparations industry, with more than 150 publications in leading industry journals. Dr. Zydney supervises the technical partnership of Chromatan with Penn State, and has been an invaluable technical resource for the company.

  • Default avatar
    Boris Napadensky
    VP of Engineering

    Boris Napadensky, VP of Engineering at ChromaTan, is a chemical engineer with 10 years of experience in leading the development and scale-up of new technologies. Boris is an accomplished technical manager with a lot of expertize in design and construction of new chemical process systems on lab, pilot and commercial scale. He is to join ChromaTan on January 16th, 2012. Boris is to lead design and construction of the Countercurrent Tangential Chrom

  • Default avatar
    Paul H. Silvis
    Board Member

    Paul founded Restek ( in 1985 to manufacture innovative, high quality chromatography products. The company’s sales exceed $60 Million and continue to outpace competitors. Paul is Chromatan's largest investor and has been an invaluable adviser as a member of the board of directors


  • Default avatar
    Vincent De Vito
    Default avatar
    Gary Bamat

Previous Investors

  • Default avatar
    Phase 1 SBIR ,Natinal Institue of Health, $183,000
    Default avatar
    Ben Franklin Technology Partners of Central Pennsylvania, $150,000
    Default avatar
    Angel Round, June 2012, $228,000